OS4.1 MEVITEM: A European, randomized, open-label, Phase I/II study of vismodegib in combination with temozolomide versus temozolomide alone in adult patients with recurrent or refractory medulloblastoma presenting an activation of the Sonic Hedgehog (SHH) pathway
Frappaz, D, Barritault, M, Montané, L, Laigle-Donadey, F, Chinot, O, Le Rhun, E, Bonneville-Levard, A, Meyronnet, D, Garin, G, Pérol, DVolume:
21
Journal:
Neuro-Oncology
DOI:
10.1093/neuonc/noz126.031
Date:
September, 2019
File:
PDF, 96 KB
2019